Upgrade to SI Premium - Free Trial

Invivyd (IVVD)

0.86 -0.04 (4.44%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/19/26)

Latest Headlines

Invivyd begins Phase 3 trial comparing COVID antibody to mRNA vaccine June 9, 2026 7:01 AM - StreetInsider Invivyd Announces First Participants Dosed in LIBERTY, a Phase 3 Clinical Trial to Evaluate the Safety and Tolerability of VYD2311 Antibody Versus mRNA COVID Vaccine and to Characterize the Safe June 9, 2026 7:01 AM - StreetInsider Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 3, 2026 7:01 AM - Globe NewsWire Invivyd completes enrollment in phase 3 COVID antibody trial June 1, 2026 7:02 AM - StreetInsider Invivyd Announces Completion of Enrollment in Upsized DECLARATION Clinical Trial, a Phase 3 Pivotal Study of VYD2311, an Investigational Antibody to Prevent COVID June 1, 2026 7:01 AM - StreetInsider Invivyd to Participate in Upcoming Investor Events May 27, 2026 7:01 AM - Globe NewsWire Form 4 Invivyd, Inc. For: May 19 Filed by: Royan Ajay May 21, 2026 4:50 PM - SEC Filing Form 4 Invivyd, Inc. For: May 19 Filed by: MCLAUGHLIN KEVIN F May 21, 2026 4:49 PM - SEC Filing Form 4 Invivyd, Inc. For: May 19 Filed by: MCGUIRE TERRANCE May 21, 2026 4:49 PM - SEC Filing Form 4 Invivyd, Inc. For: May 19 Filed by: M28 Capital Management LP May 21, 2026 4:48 PM - SEC Filing Form 4 Invivyd, Inc. For: May 19 Filed by: BOLNO PAUL May 21, 2026 4:48 PM - SEC Filing Form 4 Invivyd, Inc. For: May 19 Filed by: Berry Tamsin May 21, 2026 4:48 PM - SEC Filing Form 8-K Invivyd, Inc. For: May 19 May 19, 2026 4:05 PM - SEC Filing H.C. Wainwright Reiterates Buy Rating on Invivyd Inc. (IVVD) May 19, 2026 6:49 AM - StreetInsider Form SCHEDULE 13G/A Invivyd, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P. May 15, 2026 4:47 PM - SEC Filing Form SCHEDULE 13G/A Invivyd, Inc. Filed by: Point72 Asset Management, L.P. May 15, 2026 4:32 PM - SEC Filing Form S-8 Invivyd, Inc. May 14, 2026 4:06 PM - SEC Filing Form 10-Q Invivyd, Inc. For: Mar 31 May 14, 2026 7:19 AM - SEC Filing Form 8-K Invivyd, Inc. For: May 14 May 14, 2026 7:13 AM - SEC Filing Invivyd, Inc. (IVVD) Misses Q1 EPS by 7c May 14, 2026 7:11 AM - StreetInsider Invivyd Reports First Quarter 2026 Financial Results and Recent Business Highlights May 14, 2026 7:01 AM - Globe NewsWire Invivyd publishes research comparing COVID antibody to vaccine side effects May 11, 2026 7:01 AM - StreetInsider Invivyd and Collaborators Author New Manuscript Evaluating Early Tolerability of COVID Monoclonal Antibody and Comparing Results to COVID Vaccination May 11, 2026 7:01 AM - Globe NewsWire Invivyd to Host First Quarter 2026 Financial Results and Corporate Update Call on May 14, 2026 May 7, 2026 7:01 AM - Globe NewsWire Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 5, 2026 7:01 AM - Globe NewsWire Invivyd Announces Chairman Marc Elia to Speak at POLITICO Health Care Summit April 20, 2026 7:01 AM - Globe NewsWire H.C. Wainwright Reiterates Buy Rating on Invivyd Inc. (IVVD) April 10, 2026 6:46 AM - StreetInsider Form 8-K Invivyd, Inc. For: Apr 09 April 9, 2026 7:14 AM - SEC Filing Invivyd expands COVID-19 study, develops measles antibody candidate April 9, 2026 7:03 AM - StreetInsider Invivyd Announces REVOLUTION Program Progress and Advancement of Novel, Potential First- and Best-in-Class Measles Monoclonal Antibody Candidate VMS063 for Treatment and Prevention of Measles April 9, 2026 7:01 AM - StreetInsider Invivyd Launches “Antibodies for Any Body” in Partnership with World Champion Skier Lindsey Vonn to Inspire Actions that Help Support Immune Health April 7, 2026 10:41 AM - Globe NewsWire Invivyd Launches “Antibodies for Any Body” in Partnership with World Champion Skier Lindsey Vonn to Inspire Actions that Help Support Immune Health April 7, 2026 7:01 AM - StreetInsider Form ARS Invivyd, Inc. For: Dec 31 April 6, 2026 4:33 PM - SEC Filing Form DEFA14A Invivyd, Inc. April 6, 2026 4:25 PM - SEC Filing Form DEF 14A Invivyd, Inc. For: May 19 April 6, 2026 4:19 PM - SEC Filing Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 6, 2026 7:01 AM - Globe NewsWire Invivyd Announces Presentation at the World Vaccine Congress Washington March 30, 2026 4:05 PM - StreetInsider Full Article List